These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 24058791)

  • 1. STAT3 activation: A key factor in tumor immunoescape.
    Rébé C; Végran F; Berger H; Ghiringhelli F
    JAKSTAT; 2013 Jan; 2(1):e23010. PubMed ID: 24058791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer Patients.
    Safarzadeh E; Mohammadi A; Mansoori B; Duijf PHG; Hashemzadeh S; Khaze V; Kazemi T; Derakhshani A; Silvestris N; Baradaran B
    Front Immunol; 2020; 11():613215. PubMed ID: 33679700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells.
    Deng Y; Cheng J; Fu B; Liu W; Chen G; Zhang Q; Yang Y
    Oncogene; 2017 Feb; 36(8):1090-1101. PubMed ID: 27593937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapy.
    Dufait I; Van Valckenborgh E; Menu E; Escors D; De Ridder M; Breckpot K
    Oncotarget; 2016 Jul; 7(27):42698-42715. PubMed ID: 27029037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-17 inhibits the accumulation of myeloid-derived suppressor cells in breast cancer via activating STAT3.
    Ma M; Huang W; Kong D
    Int Immunopharmacol; 2018 Jun; 59():148-156. PubMed ID: 29655056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases.
    Thorn M; Guha P; Cunetta M; Espat NJ; Miller G; Junghans RP; Katz SC
    Cancer Gene Ther; 2016 Jun; 23(6):188-98. PubMed ID: 27199222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The STAT3 inhibitor galiellalactone inhibits the generation of MDSC-like monocytes by prostate cancer cells and decreases immunosuppressive and tumorigenic factors.
    Hellsten R; Lilljebjörn L; Johansson M; Leandersson K; Bjartell A
    Prostate; 2019 Oct; 79(14):1611-1621. PubMed ID: 31348843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway.
    Ren JP; Zhao J; Dai J; Griffin JW; Wang L; Wu XY; Morrison ZD; Li GY; El Gazzar M; Ning SB; Moorman JP; Yao ZQ
    Immunology; 2016 Aug; 148(4):377-86. PubMed ID: 27149428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autocrine IL6-Mediated Activation of the STAT3-DNMT Axis Silences the TNFα-RIP1 Necroptosis Pathway to Sustain Survival and Accumulation of Myeloid-Derived Suppressor Cells.
    Smith AD; Lu C; Payne D; Paschall AV; Klement JD; Redd PS; Ibrahim ML; Yang D; Han Q; Liu Z; Shi H; Hartney TJ; Nayak-Kapoor A; Liu K
    Cancer Res; 2020 Aug; 80(15):3145-3156. PubMed ID: 32554751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT3, a Master Regulator of Anti-Tumor Immune Response.
    Rébé C; Ghiringhelli F
    Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31480382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal transducer and activator of transcription proteins: regulators of myeloid-derived suppressor cell-mediated immunosuppression in cancer.
    Ko HJ; Kim YJ
    Arch Pharm Res; 2016 Nov; 39(11):1597-1608. PubMed ID: 27572156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients.
    Hossain DM; Pal SK; Moreira D; Duttagupta P; Zhang Q; Won H; Jones J; D'Apuzzo M; Forman S; Kortylewski M
    Clin Cancer Res; 2015 Aug; 21(16):3771-82. PubMed ID: 25967142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.
    Dysthe M; Parihar R
    Adv Exp Med Biol; 2020; 1224():117-140. PubMed ID: 32036608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOCS3 Deficiency in Myeloid Cells Promotes Tumor Development: Involvement of STAT3 Activation and Myeloid-Derived Suppressor Cells.
    Yu H; Liu Y; McFarland BC; Deshane JS; Hurst DR; Ponnazhagan S; Benveniste EN; Qin H
    Cancer Immunol Res; 2015 Jul; 3(7):727-40. PubMed ID: 25649351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion and activation of monocytic-myeloid-derived suppressor cell via STAT3/arginase-I signaling in patients with ankylosing spondylitis.
    Liu YF; Zhuang KH; Chen B; Li PW; Zhou X; Jiang H; Zhong LM; Liu FB
    Arthritis Res Ther; 2018 Aug; 20(1):168. PubMed ID: 30075733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy.
    Draghiciu O; Lubbers J; Nijman HW; Daemen T
    Oncoimmunology; 2015 Jan; 4(1):e954829. PubMed ID: 25949858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism of the premetastatic niche facilitating colorectal cancer liver metastasis generated from myeloid-derived suppressor cells induced by the S1PR1-STAT3 signaling pathway.
    Lin Q; Ren L; Jian M; Xu P; Li J; Zheng P; Feng Q; Yang L; Ji M; Wei Y; Xu J
    Cell Death Dis; 2019 Sep; 10(10):693. PubMed ID: 31534132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion of PMN-myeloid derived suppressor cells and their clinical relevance in patients with oral squamous cell carcinoma.
    Zhong LM; Liu ZG; Zhou X; Song SH; Weng GY; Wen Y; Liu FB; Cao DL; Liu YF
    Oral Oncol; 2019 Aug; 95():157-163. PubMed ID: 31345384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of STAT3 in leading the crosstalk between human cancers and the immune system.
    Wang Y; Shen Y; Wang S; Shen Q; Zhou X
    Cancer Lett; 2018 Feb; 415():117-128. PubMed ID: 29222039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
    Yu J; Du W; Yan F; Wang Y; Li H; Cao S; Yu W; Shen C; Liu J; Ren X
    J Immunol; 2013 Apr; 190(7):3783-97. PubMed ID: 23440412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.